Nov. 8, 2012 | Allgemein, company news @en, DE
The drug manufacturer Stada made a profit of EUR 20.5 million in the third quarter after a large loss of EUR 62.4 million a year earlier. This is an important step for the Group in the Hessian town of Bad Vilbel, following the expansion to Eastern Europe where...
Nov. 8, 2012 | Allgemein, company news @en, DE
The German biotech company Morphosys has reduced losses in the third quarter of 2012 due to lower research spending to EUR 0.4 million from EUR 3.4 million a year earlier. However, the company – with its headquarters in Martinsried – continued in the...
Nov. 8, 2012 | Allgemein, company news @en, DE
The Frankish Rhön-Klinikum hospital operator has suffered in the first nine months of the current fiscal year under special items. The delayed restructuring at University Hospital Giessen-Marburg and financial consequences of the failed takeover bid by Fresenius have...
Nov. 8, 2012 | Allgemein, company news @en, DE
The medical technology company Eckert & Ziegler has experienced a double-digit sales increase of 11.2 percent to EUR 21.8 million in the first nine months of fiscal year 2012. However, the profit of EUR 1.04 million fell to EUR 0.9 million. EBIT fell by 3.6...
Nov. 8, 2012 | Allgemein, company news @en, DE, transactions
Takeda, the largest pharmaceutical company in Japan, is expanding further with the takeover of drug discovery group Envoy from Florida. The transaction, valued at $140 million, offers Takeda access to Envoy’s „BacTrap“ technology to mark and extract...
Nov. 7, 2012 | Allgemein, company news @en, DE
The Dutch biotech company Qiagen has increased its total sales in the third quarter of 2012 at constant exchange rates by ten percent to $304.3 million (EUR 238 million). Double-digit growth was registered in the U.S. and Asia, the company with its headquarters in...
